Jore, Joselito R.
HRN: 27-32-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/13/2025
06/19/2025
IVT
2.25g
Q6H
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes